8-K: USPH Updates Investor Presentation, Highlights Growth

U.S. Physical Therapy, Inc. updated its investor presentation, showcasing strong financial performance, strategic growth, and market leadership in outpatient physical therapy and injury prevention services.

Summary

• Operate 768 owned/managed outpatient physical and occupational therapy clinics across 44 states.
• Industrial injury prevention services account for 15% of revenue.
• Reported $730 million in Trailing Twelve Months (TTM) revenues and $89 million in TTM Adjusted EBITDA as of June 30, 2025.
• Achieved 18% year-over-year revenue growth for the six months ended June 30, 2025, compared to the same period in 2024.
• Maintain an annual dividend of $1.80.
• Added 95 new clinics (de novo and acquisitions) since July 1, 2024.
• Average daily visits per clinic reached an all-time high of 32.7.
• Industrial Injury Prevention services revenue grew 22.6% and gross profit grew 25.8% in Q2 2025.
• Maintain a strong balance sheet with $112.9 million in cash and $142.5 million outstanding on the term loan as of June 30, 2024.

Sentiment

Score: 8

Explanation: The company demonstrates strong financial performance with significant revenue growth, record patient volumes, and improved profitability. Its strategic position in a fragmented, growing market, coupled with a proven acquisition and partnership model, indicates robust operational health. While general industry risks exist, the overall outlook presented is highly positive.

Positives

• Strong financial position with $112.9 million in cash as of June 30, 2024, and $175 million available under the revolving facility.
• Achieved 18% year-over-year revenue growth for the six months ended June 30, 2025.
• Record-high average daily visits per clinic at 32.7, indicating strong patient demand and operational efficiency.
• Industrial Injury Prevention services revenue increased by 22.6% and gross profit by 25.8% in Q2 2025, demonstrating robust segment performance.
• Demonstrated consistent growth over the last decade with an 8% CAGR for revenue and 9% CAGR for Adjusted EBITDA from 2013-2024.
• Adjusted EBITDA margin for Q2 2025 was 17.6%, an improvement from 16.4% in Q2 2024, reflecting enhanced profitability.
• Successful acquisition strategy, having completed over 50 acquisitions since 2005, contributing to expansion.
• Highly retentive partnership model for clinic operations, fostering strong alignment with experienced physical therapists.
• Favorable demographic trends, including an aging, physically active, and obese population, support sustained market growth.
• Outpatient clinics are the leading setting for care, with physical therapy demonstrating significant ROI for payors, including average overall savings of approximately $6,000 and lower readmission rates for procedures like hip replacement surgery.

Negatives

• Incurred clinic closure costs of $0.2 million and $0.3 million for the three and six months ended June 30, 2025, respectively, related to the closure of ten and eleven clinics.

Risks

• Changes in Medicare rules, guidelines, and reimbursement, or failure to maintain Medicare certification and/or enrollment status.
• Revenue from Medicare and Medicaid is subject to potential retroactive reduction.
• Changes in reimbursement rates or payment methods from third-party payors, including government agencies, and changes in patient deductibles and co-pays.
• Private third-party payors may adopt payment policies that could limit future revenue and profitability.
• Compliance with federal and state laws and regulations relating to the privacy of individually identifiable patient information (HIPAA) and corporate practice of medicine/fee splitting, with associated fines and penalties for non-compliance.
• Competitive, economic, or reimbursement conditions in markets may require reorganization or closure of clinics, leading to losses, closure costs, or write-downs of goodwill and other intangible assets.
• Impact of future public health crises and epidemics/pandemics, such as COVID-19 and its variants.
• Certain acquisition agreements contain put-rights related to a future purchase of significant equity interests in subsidiaries or separate companies.
• Impact of future vaccinations and/or testing mandates at federal, state, and/or local levels, which could adversely affect staffing, revenue, costs, and results of operations.
• Debt and financial obligations could adversely affect financial condition, ability to obtain future financing, and business operations.
• Changes resulting from government-enacted national healthcare reform.
• Ability to control variable interest entities for which there is no direct ownership.
• Governmental and other third-party payor inspections, reviews, investigations, and audits, which may result in sanctions, reputational harm, and increased costs.
• Contingent consideration provisions in certain acquisition agreements, the value of which may impact future financial results.
• Legal actions, which could subject the company to increased operating costs and uninsured liabilities.
• General economic conditions, including inflationary and recessionary periods.
• Actual or perceived events involving banking volatility or limited liability, defaults, or other adverse developments affecting U.S. or international financial systems, potentially resulting in market-wide liquidity problems.
• Business depends on hiring, training, and retaining qualified employees, and the availability and cost of qualified physical therapists.
• Competitive environment in the industrial injury prevention services business, which could result in termination or non-renewal of contractual service arrangements.
• Ability to identify and complete acquisitions, and the successful integration of acquired businesses.
• Impact on business and cash reserves resulting from retirement or resignation of key partners and resulting purchase of their non-controlling interest (minority interests).
• Maintaining information technology systems with adequate safeguards to protect against cyber-attacks; security breaches may lead to legal action, reputational harm, or HIPAA violations.
• Maintaining clients for management, industrial injury prevention, and other services, as a breach or termination of those contractual arrangements could cause operating results to be less than expected.
• Maintaining adequate internal controls and necessary insurance coverage.
• Availability, terms, and use of capital.
• Weather and other seasonal factors.

Future Outlook

The company anticipates continued organic growth through de novo clinic openings and strategic acquisitions, aiming to maximize profits from existing facilities by increasing patient volume, improving pricing, enhancing efficiencies, and adding new programs and services. It also expects to maintain a strong balance sheet and continue its capital allocation strategy, including dividend issuances and potential share repurchases.

Management Comments

• Our business depends on hiring, training, and retaining qualified employees.
• We continue to see record-high volumes.
• Average daily visits per clinic was an all-time high of 32.7.

Industry Context

The U.S. rehabilitation market is valued at over $40 billion, highly fragmented with no single company holding more than 10% market share. U.S. Physical Therapy, Inc. operates as one of the largest owner/operator platforms, well-positioned to capitalize on market consolidation trends. Favorable demographic shifts, including an aging, physically active, and obese population, are driving demand for musculoskeletal injury treatment. The healthcare delivery model is shifting towards lower-cost, high-quality outpatient providers, benefiting companies like USPH. Physical therapy offers significant ROI for payors, demonstrating average savings of approximately $6,000 and lower readmission rates for procedures like hip replacement surgery when physical therapy is utilized.

Comparison to Industry Standards

• The U.S. outpatient rehabilitation market is highly fragmented with over 37,000 clinics, and no company holds greater than 10% market share, positioning USPH as a significant consolidator.
• Select Medical is cited as a proxy for the largest physical therapy operator in the U.S. with 1,925 outpatient rehabilitation clinics as of September 30, 2024, compared to USPH's 768 owned/managed clinics as of June 30, 2025, indicating USPH's substantial, though not dominant, market presence.
• USPH's 18% year-over-year revenue growth for the six months ended June 30, 2025, and 8% CAGR for revenue (2013-2024) demonstrate strong performance relative to the fragmented industry landscape.
• The company's partnership model, where clinic founders retain significant ownership (20% to 50%) and receive monthly cash distributions, aligns interests and is a key differentiator in attracting and retaining experienced physical therapists, contrasting with models that fully acquire and integrate.
• The average overall savings of approximately $6,000 with significantly lower readmission rates for hip replacement surgery with physical therapy, as highlighted in the presentation, underscores the value proposition of outpatient PT services compared to traditional inpatient care, aligning with broader healthcare cost-containment trends.

Related Party Transactions

• Acquisition agreements contain put-rights related to a future purchase of significant equity interests in subsidiaries or separate companies.
• Impact on business and cash reserves resulting from retirement or resignation of key partners and resulting purchase of their non-controlling interest (minority interests).

Stakeholder Impact

• Shareholders: Potential for continued value return through dividends and potential share repurchases; positive impact from strong financial performance and growth strategy.
• Employees: Business depends on hiring, training, and retaining qualified employees, particularly physical therapists; potential impact from vaccination/testing mandates.
• Patients: Focus on patient-centric care model, lower costs, and high quality; potential for improved access to care through clinic expansion.
• Partners (clinic founders): Partnership model allows significant ownership retention (20-50%) and monthly cash distributions, with agreements to purchase remaining interest, creating strong alignment and potential for future liquidity events.
• Clients (Industrial Injury Prevention): Maintaining clients is crucial, as breach or termination of contractual arrangements could negatively impact operating results.
• Payors: Increased likelihood of selection for payor networks due to scale; some limited leverage in negotiations for reimbursement.

Next Steps

• Drive organic growth through de novo physical and occupational therapy clinic openings.
• Maximize profits of existing facilities by growing patient volume, improving pricing, increasing efficiencies, and adding programs and services.
• Augment organic growth through strategic acquisitions.
• Maintain strategic flexibility and a conservative balance sheet.
• Minimize interest expense.
• Continue dividend issuances.
• Develop de novo physical therapy clinics, increase industrial injury locations, and add services in both businesses.
• Potentially repurchase up to $25 million in shares if market conditions are appropriate.

Key Dates

Recommendation

The company demonstrates robust financial health with 18% year-over-year revenue growth and record patient volumes, indicating strong operational execution and market demand. Its strategic position as a consolidator in a highly fragmented, growing healthcare market, coupled with a proven partnership and acquisition model, provides a clear path for continued expansion. The improved Adjusted EBITDA margin and consistent dividend payments further enhance its attractiveness. While general industry risks exist, the overall positive trajectory and strong fundamentals make it a compelling investment.

Keywords

Physical Therapy, Outpatient Rehabilitation, Industrial Injury Prevention, Healthcare Services, Clinic Operations, USPH, SEC Filing, Investor Presentation, Healthcare Investment